+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
351003-02-6,MFCD11557230
Catalog No.:AA0037YH

351003-02-6 | 5-Bromo-2-methylpyridine-3-carboxylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$10.00   $7.00
- +
250mg
97%
in stock  
$13.00   $9.00
- +
1g
97%
in stock  
$29.00   $20.00
- +
5g
97%
in stock  
$94.00   $66.00
- +
25g
97%
in stock  
$318.00   $222.00
- +
100g
97%
in stock  
$1,268.00   $888.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0037YH
Chemical Name:
5-Bromo-2-methylpyridine-3-carboxylic acid
CAS Number:
351003-02-6
Molecular Formula:
C7H6BrNO2
Molecular Weight:
216.0320
MDL Number:
MFCD11557230
SMILES:
Brc1cnc(c(c1)C(=O)O)C
Properties
Computed Properties
 
Complexity:
163  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP3327019,2018,A1Locationinpatent:Paragraph0238

[1]CurrentPatentAssignee:TANGOTHERAPEUTICS-WO2022/26892,2022,A1Locationinpatent:Paragraph0568

[2]CurrentPatentAssignee:TANGOTHERAPEUTICS-WO2022/26892,2022,A1Locationinpatent:Paragraph0568

[3]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155320,2021,A1Locationinpatent:Page/Pagecolumn71;126-127

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP3327019,2018,A1Locationinpatent:Paragraph0243

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/238616,2019,A1

[2]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155320,2021,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 351003-02-6
1190862-72-6

1190862-72-6

 129477-21-0

129477-21-0

 1215916-40-7

1215916-40-7

 20826-04-4

20826-04-4

 677702-58-8

677702-58-8

 93350-01-7

93350-01-7
Building Blocks
More >
Tags:351003-02-6 Molecular Formula|351003-02-6 MDL|351003-02-6 SMILES|351003-02-6 5-Bromo-2-methylpyridine-3-carboxylic acid
Catalog No.: AA0037YH
351003-02-6,MFCD11557230
351003-02-6 | 5-Bromo-2-methylpyridine-3-carboxylic acid
Pack Size： 100mg
Purity： 97%
in stock
$10.00 $7.00
Pack Size： 250mg
Purity： 97%
in stock
$13.00 $9.00
Pack Size： 1g
Purity： 97%
in stock
$29.00 $20.00
Pack Size： 5g
Purity： 97%
in stock
$94.00 $66.00
Pack Size： 25g
Purity： 97%
in stock
$318.00 $222.00
Pack Size： 100g
Purity： 97%
in stock
$1,268.00 $888.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0037YH
Chemical Name: 5-Bromo-2-methylpyridine-3-carboxylic acid
CAS Number: 351003-02-6
Molecular Formula: C7H6BrNO2
Molecular Weight: 216.0320
MDL Number: MFCD11557230
SMILES: Brc1cnc(c(c1)C(=O)O)C
Properties
Complexity: 163  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.5  
Downstream Synthesis Route
351003-02-6    74-88-4    1215916-40-7 

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP3327019,2018,A1Locationinpatent:Paragraph0238

67-56-1    351003-02-6    1215916-40-7 

[1]CurrentPatentAssignee:TANGOTHERAPEUTICS-WO2022/26892,2022,A1Locationinpatent:Paragraph0568

[2]CurrentPatentAssignee:TANGOTHERAPEUTICS-WO2022/26892,2022,A1Locationinpatent:Paragraph0568

[3]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155320,2021,A1Locationinpatent:Page/Pagecolumn71;126-127

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP3327019,2018,A1Locationinpatent:Paragraph0243

351003-02-6    1256823-89-8 

[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2019/238616,2019,A1

[2]CurrentPatentAssignee:FOGHORNTHERAPEUTICSINC-WO2021/155320,2021,A1

Related Products of of 351003-02-6
1190862-72-6
1190862-72-6
129477-21-0
129477-21-0
1215916-40-7
1215916-40-7
20826-04-4
20826-04-4
677702-58-8
677702-58-8
93350-01-7
93350-01-7
Building Blocks More >
137-16-6
137-16-6
N-Lauroylsarcosine sodium salt hydrate
AA00381P | MFCD00042728
112648-68-7
112648-68-7
U-73122
AA003850 | MFCD12910450
117704-25-3
117704-25-3
25-Cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)avermectin A1a
AA00388H | MFCD00894747
851386-34-0
851386-34-0
2,3-Difluoro-4-iodopyridine
AA0038BI | MFCD09909609
694-32-6
694-32-6
1-Methyl-2-imidazolidinone
AA0038EO | MFCD00800601
637031-93-7
637031-93-7
3,3-Difluorocyclobutanamine HCl
AA0038I3 | MFCD10001382
5426-59-5
5426-59-5
6-Bromo-2-methylquinazolin-4(3H)-one
AA0038L1 | MFCD00548197
391-77-5
391-77-5
4-Chloro-6-fluoroquinoline
AA0038OB | MFCD00278783
28230-32-2
28230-32-2
3-Hydroxy-1,2,3-ben zotriazin-4(3H)-one
AA0038RJ | MFCD00042803
149794-10-5
149794-10-5
Boc-N-ethyl glycine
AA0038UN | MFCD00672508
Submit
© 2017 AA BLOCKS, INC. All rights reserved.